Get started
Author

Vincent Philiponis

Observed name: Vince Philiponis
ORCID: 0009-0009-3287-382X
Observed ORCIDs: 0009-0009-3287-382X, 0000-0003-2495-2498
OpenAlex ID: A5088876845
Vaccination induces HIV broadly neutralizing antibody precursors in humans
2022 · David J. Leggat, Kristen W. Cohen, et al. · Science · 308
A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses
2023 · Kristen W. Cohen, Stephen C. De Rosa, et al. · Science Translational Medicine · 80
PDF
Precise targeting of HIV broadly neutralizing antibody precursors in humans
2025 · Tom G. Caniels, Madhu Prabhakaran, et al. · Science · 64
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming
2024 · Allan C. deCamp, Martin M. Corcoran, et al. · npj Vaccines · 41
PDF
Safety and Immunogenicity of an rVSV Lassa Fever Vaccine Candidate
2025 · Elissa Malkin, Marija Zaric, et al. · New England Journal of Medicine · 25
PDF
Ultrasound-guided lymph node fine-needle aspiration for evaluating post-vaccination germinal center responses in humans
2023 · Larissa L.S. Scholte, David J. Leggat, et al. · STAR Protocols · 6
Safety and immunogenicity of a recombinant vesicular stomatitis virus-based Sudan virus vaccine in adults in the USA: a single-blind, first-in-human, dose-escalation phase 1 clinical trial
2026 · Dagna S Laufer, Arianna Marini, et al. · The Lancet Microbe · 1
Sequential vaccination matures VRC01-class HIV-1 neutralizing antibodies in humans
2026 · Tom G. Caniels, Madhu Prabhakaran, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Works count: 8
Citation count: 525
H-index: 6
I10-index: 5
Year
Topic
Type